C. Goldsmith

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients

R. Hogg, J. Montaner, M. Wainberg, 2017, BMC Infectious Diseases.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2017, BMC Infectious Diseases.

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

P. Harrigan, B. Yip, R. Hogg, 2016, BMC Infectious Diseases.

The 'Expanded HIV care in opioid substitution treatment' (EHOST) cluster-randomized, stepped-wedge trial: A study protocol.

J. Montaner, E. Wood, E. Krebs, 2015, Contemporary clinical trials.